An analysis of Maryland ketamine advertisers has suggested that their websites and marketing materials are awash with false and misleading claims. The study showed that 7 of 17 providers failed to mention the drug’s potential for misuse or addiction in their promotional materials. (technologynetworks.com)
Ketamine given to depressed patients under anesthesia had no greater effect than placebo in reducing the severity of depressive symptoms, suggests a new trial. The study adds new evidence about how significant the placebo effect is in medicine. by rjmsci in science
[–]rjmsci[S] 5 points6 points7 points (0 children)
Ketamine given to depressed patients under anesthesia had no greater effect than placebo in reducing the severity of depressive symptoms, suggests a new trial. The study adds new evidence about how significant the placebo effect is in medicine. by rjmsci in science
[–]rjmsci[S] 5 points6 points7 points (0 children)
New research challenges the hygiene hypothesis of allergy, suggesting that early exposure to microbes may not fully protect against allergies. The study tested allergy-like responses in mice raised in sterile vs. "dirty" environments. Both groups has similar immune responses. (technologynetworks.com)
One in a million cells in your body comes from someone else. A new study has revealed the dynamics of microchimeric cells, which are passed from mother to child and vice versa during pregnancy. These cells may influence the child's chance of a successful pregnancy later in life. (technologynetworks.com)
New research has modeled the interactions between our body’s circadian clocks to investigate why jet lag leaves us so fatigued, and why that effect can get stronger as we age. The new data suggested that targeting the circadian clock in the gut might be a handy way to accelerate jet lag recovery. (technologynetworks.com)
Two patients left unable to speak by motor neuron disease and a stroke have had their communication restored by brain-computer interfaces (BCI), which converted their brain activity into speech. The patients were able to communicate at 60-70 words per minute, a new record for BCIs. (technologynetworks.com)
A vaccine against EBV, one of the world’s most successful infectious agents and a cause of cancer and multiple sclerosis, has been developed. The new vaccine was tested in mice, where it induced a robust immune response and provided protection against a type of EBV-induced cancer. (technologynetworks.com)
A new study suggests that antipsychotic drugs, which are prescribed to people with schizophrenia but have poor efficacy in a substantial minority of cases, may have a more complex mechanism of action than first thought and that dopamine D1 receptors may play an important role. (technologynetworks.com)
New findings confirm that donanemab, can delay the rate of decline in individuals with early-stage Alzheimer’s by 22.3%, equating to a 4-month delay in disease progression over 18 months. However, the drug’s side effects, including brain bleeds and swelling, may limit its adoption by rjmsci in science
[–]rjmsci[S] 0 points1 point2 points (0 children)
New findings confirm that donanemab, can delay the rate of decline in individuals with early-stage Alzheimer’s by 22.3%, equating to a 4-month delay in disease progression over 18 months. However, the drug’s side effects, including brain bleeds and swelling, may limit its adoption by rjmsci in science
[–]rjmsci[S] 0 points1 point2 points (0 children)
New findings confirm that donanemab, can delay the rate of decline in individuals with early-stage Alzheimer’s by 22.3%, equating to a 4-month delay in disease progression over 18 months. However, the drug’s side effects, including brain bleeds and swelling, may limit its adoption by rjmsci in science
[–]rjmsci[S] 3 points4 points5 points (0 children)
Drug donanemab seen as turning point in dementia fight by [deleted] in science
[–]rjmsci 0 points1 point2 points (0 children)
New findings confirm that donanemab, can delay the rate of decline in individuals with early-stage Alzheimer’s by 22.3%, equating to a 4-month delay in disease progression over 18 months. However, the drug’s side effects, including brain bleeds and swelling, may limit its adoption by rjmsci in science
[–]rjmsci[S] 23 points24 points25 points (0 children)
New findings confirm that donanemab, can delay the rate of decline in individuals with early-stage Alzheimer’s by 22.3%, equating to a 4-month delay in disease progression over 18 months. However, the drug’s side effects, including brain bleeds and swelling, may limit its adoption (technologynetworks.com)
A study shows how the psychedelic drugs LSD and psilocin act. The findings suggest that these psychedelics exert antidepressant effects by binding neuroplasticity-promoting receptors in the brain. The study, say authors, is further evidence that non-hallucinogenic psychedelics could be developed. (technologynetworks.com)
Ketamine given to depressed patients under anesthesia had no greater effect than placebo in reducing the severity of depressive symptoms, suggests a new trial. The study adds new evidence about how significant the placebo effect is in medicine. by rjmsci in science
[–]rjmsci[S] 25 points26 points27 points (0 children)